This content has not yet been reviewed and may contain errors.

dialysis overview

in review 4 min read Updated 2026-08-24
Contents
Dialysis clears solute (diffusion, convection) and solvent (ultrafiltration) through extracorporeal or peritoneal circuits. HD 3x/week is standard for ESKD; CRRT for haemodynamically unstable ICU patients; PD for home-based therapy. Access is the lifeline — protect veins early.

principles

Two jobs, handled separately:

  • Solvent (water) clearance — ultrafiltration via pressure gradient: barometric (HD) or osmotic (PD)
  • Solute clearance — diffusion (concentration gradient across membrane) + convection (solute dragged with water movement)

access

TypeDetailsNotes
Temporary catheterNon-tunnelled, internal jugular or femoralShort-term only; reassess daily
Tunnelled catheter (PermCath)Subcutaneous cuff, internal jugularBridge to permanent access or when AVF/AVG not feasible
AVFNative arteriovenous fistulaPreferred — lowest infection/thrombosis; needs 2–3 months to mature
AVGSynthetic graftUsable in ~2–4 weeks; higher thrombosis/infection than AVF
protect the veins

Avoid CVL/PICC lines in CKD patients whenever possible — venous stenosis/thrombosis destroys future access sites. Minimise venipuncture in dialysis patients; draw labs from the dialysis circuit 3x/week.


haemodialysis prescription

Standard chronic HD:

ParameterDefault
Frequency3x/week (MWF or TuThSa)
Duration4 h
Blood flow (Qb)400 mL/min
Dialysate flow (Qd)500 mL/min
Dialysate Na140 mmol/L (should not exceed serum Na by >10)
Dialysate KRule of 7 minus pre-dialysis K (options: 1, 1.5, 3, 4 mmol/L)
Dialysate HCO330–40 mmol/L
Dialysate Ca1.25 or 1.50 mmol/L
UF rateAvoid >13 mL/kg/hr (~1 L/hr for 70 kg)
AnticoagulationDalteparin 2500 units (tight)

Dalteparin contraindications: HIT, pericarditis, new HD starts, recent major bleeding or surgery.

new HD start

Gradual ramp to avoid dialysis disequilibrium syndrome (cerebral oedema from rapid osmolality shifts):

Day 1Day 2Day 3
Duration2 h3 h4 h
Qb200 mL/min300 mL/min400 mL/min
Qd300 mL/min400 mL/min500 mL/min
AnticoagulationNoneNoneStart as appropriate

CRRT

ICU-only modality for haemodynamically unstable patients who cannot tolerate intermittent HD.

  • Default mode: CVVHD (continuous venovenous haemodialysis)
  • Filters changed every 72 h — natural reassessment point: still need CRRT or ready for intermittent HD?
  • Machine taken down for off-unit transport; fresh filter on return
  • Anticoagulation escalation: none (default) → regional citrate (if filter clotting) → systemic heparin
  • Cost: ~10002000/dayvsintermittentHD 1000–2000/day vs intermittent HD ~250/treatment
CRRT vs intermittent HD

STARRT-AKI (2020) showed no mortality benefit from early RRT initiation. Modality choice (CRRT vs iHD) is driven by haemodynamic tolerance, not timing.


peritoneal dialysis

Home-based therapy using the peritoneal membrane as the dialysis surface. Dextrose-based dialysate creates an osmotic gradient for fluid removal.

solutions

SolutionCompositionNotes
Dianeal 1.5%Dextrose ~8.3 mmol/L glucoseStandard
Dianeal 2.5%Dextrose ~13.9 mmol/L glucoseMore UF
Dianeal 4.25%Dextrose ~23.6 mmol/L glucoseMaximum UF; significant glucose load
Extraneal (icodextrin)Glucose polymerMinimal glucose absorption — preferred for diabetics and long dwells

modalities

  • CAPD — continuous ambulatory PD: manual exchanges, typically 4x/day
  • APD/CCPD — automated/continuous cycling PD: machine performs overnight exchanges

Generally continue home PD prescription during hospital admission. Modify for volume overload (higher concentration) or hyperkalaemia.

PD and glucose

Dianeal dextrose loads can cause significant hyperglycaemia — adjust insulin accordingly. Extraneal (icodextrin) has minimal glucose effect but interferes with some glucometer readings (maltose cross-reactivity).


practical points

  • No need to repeat lytes post-HD unless concerned about dialysis adequacy or persistent hyperkalaemia — they will be transiently abnormal
  • Do not correct serum K in dialysis patients unless <2 mmol/L or symptomatic — risk of rebound hyperkalaemia
  • Dialysis nurses are experienced — ask them when unsure about access or prescription logistics

Key references